MX9705806A - Forma farmaceutica destinada a la cesion de colagenasa en heridas, y procedimiento para su elaboracion. - Google Patents

Forma farmaceutica destinada a la cesion de colagenasa en heridas, y procedimiento para su elaboracion.

Info

Publication number
MX9705806A
MX9705806A MX9705806A MX9705806A MX9705806A MX 9705806 A MX9705806 A MX 9705806A MX 9705806 A MX9705806 A MX 9705806A MX 9705806 A MX9705806 A MX 9705806A MX 9705806 A MX9705806 A MX 9705806A
Authority
MX
Mexico
Prior art keywords
collagenase
wounds
delivery
preparation
medicament
Prior art date
Application number
MX9705806A
Other languages
English (en)
Inventor
Michael Roreger
Heinz Einig
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of MX9705806A publication Critical patent/MX9705806A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Una forma farmacéutica destinada a la cesion de colagenasa en heridas se caracteriza porque es coherente, conformable y de forma plana, su extension superficial es de igual o menor tamaño que la superficie de la herida a tratar, y contiene colagenasa en cantidades definidas y distribuida en forma homogénea.
MX9705806A 1995-02-02 1997-07-30 Forma farmaceutica destinada a la cesion de colagenasa en heridas, y procedimiento para su elaboracion. MX9705806A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19503338A DE19503338C2 (de) 1995-02-02 1995-02-02 Arzneiform zur Abgabe von Kollagenase an Wunden und Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
MX9705806A true MX9705806A (es) 1998-07-31

Family

ID=7752981

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9705806A MX9705806A (es) 1995-02-02 1997-07-30 Forma farmaceutica destinada a la cesion de colagenasa en heridas, y procedimiento para su elaboracion.

Country Status (27)

Country Link
US (1) US6074664A (es)
EP (1) EP0809489B1 (es)
JP (1) JP2000515485A (es)
KR (1) KR19980701888A (es)
CN (1) CN1182364A (es)
AR (1) AR001078A1 (es)
AT (1) ATE201136T1 (es)
AU (1) AU707364B2 (es)
BG (1) BG101802A (es)
BR (1) BR9606997A (es)
CA (1) CA2212059A1 (es)
CZ (1) CZ290943B6 (es)
DE (2) DE19503338C2 (es)
DK (1) DK0809489T3 (es)
ES (1) ES2159013T3 (es)
FI (1) FI972949A (es)
GR (1) GR3036384T3 (es)
HU (1) HUP0202088A2 (es)
MX (1) MX9705806A (es)
NO (1) NO973525D0 (es)
NZ (1) NZ300202A (es)
PL (1) PL182849B1 (es)
PT (1) PT809489E (es)
SK (1) SK282578B6 (es)
TR (1) TR199700734T1 (es)
WO (1) WO1996023487A1 (es)
ZA (1) ZA96795B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19710190A1 (de) * 1997-03-12 1998-09-17 Immuno Ag Aktivierter Vitamin K-abhängiger Blutfaktor und Verfahren zu dessen Herstellung
DE19829789A1 (de) * 1998-07-03 2000-01-05 Beiersdorf Ag Gegen Akne und entzündete Comedonen wirksame Zubereitungen enthaltend Serin-Proteasen und ein oder mehrere Calciumsalze
IL127209A0 (en) * 1998-11-23 1999-09-22 Bio Silk Ltd Composition and method for treatment of hypertrophic skin accumulations and their prevention
US7632494B2 (en) * 1999-09-24 2009-12-15 Proteon Therapeutics, Inc. Methods for enlarging the diameter of a biological conduit in a human subject
US7063838B1 (en) * 1999-09-24 2006-06-20 Proteon Therapeutics Llc Methods for treating an artery or vein in a human subject
US6756051B1 (en) * 2000-11-15 2004-06-29 Li-Lan H. Chen Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same
DE10117916C2 (de) * 2001-04-10 2003-03-20 Christa Stolz Faltbares mit Creme beschichtetes Folienelement (Folienschuh) zur hygienischen Aufbringung von Fußcreme bei der Anwendung von mechanischen Fußmassagevorrichtungen
US20100159564A1 (en) * 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
US9694100B2 (en) * 2009-12-08 2017-07-04 Smith & Nephew, Inc. Enzymatic wound debriding compositions with enhanced enzymatic activity
US9822257B2 (en) 2012-07-23 2017-11-21 Crayola Llc Dissolvable films and methods of using the same
US20150196625A9 (en) 2013-01-07 2015-07-16 Rudolph D. Paladini Metal Sensitive Mutants of Matrix Metalloproteases and uses thereof
US10137179B2 (en) 2016-05-18 2018-11-27 Hyalo Technologies, LLC Composition and method of preparation of protease microparticulate slow release preparation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2432925C3 (de) * 1974-07-05 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen Folienförmige Arzneimittel
FR2488797A1 (fr) * 1980-08-19 1982-02-26 Lhd Lab Hygiene Dietetique Composition dermatologique, son procede de preparation et son application dans le domaine des pansements
ZA818919B (en) * 1981-04-13 1982-11-24 Seton Co Cosmetic and pharmaceutical sheet material containing polypeptides
DE3139089A1 (de) * 1981-10-01 1983-04-14 Röhm Pharma GmbH, 6100 Darmstadt Flaechengebilde auf proteinbasis als traeger therapeutisch wirksamer, nicht-immobilisierter enzyme
GB2150833B (en) * 1983-12-08 1987-04-15 Ceskoslovenska Akademie Ved Proteolytic wounds dressing
CA1256772A (en) * 1985-02-26 1989-07-04 Sudhakar S. Wagle Bandage for the topical administration of controlled amounts of nitroglycerin ointment
US4668228A (en) * 1985-03-12 1987-05-26 Johnson & Johnson Products, Inc. Debriding tape
DE3606265A1 (de) * 1986-02-27 1987-09-03 Roehm Pharma Gmbh Wundauflage auf polysaccharidbasis als traeger therapeutisch wirksamer, nicht-immobilisierter enzyme und mit hoher saugfaehigkeit
DE3630603A1 (de) * 1986-09-09 1988-03-10 Desitin Arzneimittel Gmbh Darreichungs- und dosierungsform fuer arzneimittelwirkstoffe, reagentien oder dergleichen sowie verfahren zu deren herstellung
DE3631413A1 (de) * 1986-09-16 1988-03-24 Knoll Ag Therapeutisches system zur lokalen applikation von pharmawirkstoffen
US5227157A (en) * 1986-10-14 1993-07-13 Board Of Regents, The University Of Texas System Delivery of therapeutic agents
DE8709810U1 (de) * 1987-07-16 1987-10-08 E.R. Squibb & Sons, Inc., Princeton, N.J. Medizinisches Pflaster
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5206026A (en) * 1988-05-24 1993-04-27 Sharik Clyde L Instantaneous delivery film
DE8902311U1 (de) * 1989-02-27 1989-05-11 Berg, Heide von, 8000 München Heilpflaster
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
DE4230589C1 (de) * 1992-09-12 1994-02-03 Lohmann Therapie Syst Lts Dosierverfahren für leicht flüchtige oder thermolabile Substanzen in flüssiger Form zur Herstellung von u.a. flächigen Arzneiformen, insbesondere zur Herstellung von transdermalen oder dermalen therapeutischen Systemen
IL104734A0 (en) * 1993-02-15 1993-06-10 Univ Bar Ilan Bioactive conjugates of cellulose with amino compounds

Also Published As

Publication number Publication date
DE19503338A1 (de) 1996-08-08
BR9606997A (pt) 1997-10-28
EP0809489B1 (de) 2001-05-16
SK101597A3 (en) 1998-04-08
EP0809489A1 (de) 1997-12-03
NO973525L (no) 1997-07-31
FI972949A (fi) 1997-08-28
CA2212059A1 (en) 1996-08-08
PL321810A1 (en) 1997-12-22
HUP0202088A2 (en) 2002-09-28
ATE201136T1 (de) 2001-06-15
SK282578B6 (sk) 2002-10-08
FI972949A0 (fi) 1997-07-11
US6074664A (en) 2000-06-13
WO1996023487A1 (de) 1996-08-08
DE59606907D1 (de) 2001-06-21
GR3036384T3 (en) 2001-11-30
ES2159013T3 (es) 2001-09-16
JP2000515485A (ja) 2000-11-21
CN1182364A (zh) 1998-05-20
KR19980701888A (ko) 1998-06-25
PT809489E (pt) 2001-10-31
CZ221997A3 (en) 1997-12-17
NZ300202A (en) 1999-10-28
AU707364B2 (en) 1999-07-08
NO973525D0 (no) 1997-07-31
TR199700734T1 (xx) 1998-02-21
AU4487396A (en) 1996-08-21
DE19503338C2 (de) 1998-07-30
BG101802A (en) 1998-02-27
CZ290943B6 (cs) 2002-11-13
AR001078A1 (es) 1997-09-24
DK0809489T3 (da) 2001-09-10
PL182849B1 (pl) 2002-03-29
ZA96795B (en) 1996-07-16

Similar Documents

Publication Publication Date Title
WO1996025922A3 (en) Banded prolonged release active agent dosage form
NZ308293A (en) Antibacterial-wound healing compositions comprising a pyruvate, antioxidant and fatty acids
AU3990797A (en) Sustained release formulation
AU4718496A (en) Use of aerogels in agriculture
IL127581A0 (en) Crystal form i of clarithromycin
GB2292316B (en) Nasal drug delivery composition containing nicotine
MY113488A (en) Compounds with growth hormone releasing properties
HU900108D0 (en) Composition of controlled active ingredient delivery, operating by hydrogel
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
MX9705806A (es) Forma farmaceutica destinada a la cesion de colagenasa en heridas, y procedimiento para su elaboracion.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
MX9703354A (es) Composiciones para tratar el acné y curar heridas que contienen un piruvato, un antioxidante y una mezcla de acidos grasos.
DE69527509D1 (de) Hydrogelformulierung mit gesteuerter freisetzung
HK1015255A1 (en) High viscosity liquid controlled derlivery system
SE9504077D0 (sv) Vätskeabsorberande artikel ansedd för engångsanvändning
WO1998053850A3 (en) Compositions and means for the treatment of burns and other cutaneous traumas
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
NZ515685A (en) Use of riluzole for the treatment of multiple sclerosis
NZ333443A (en) Method of treating a plant disease comprising applying oxi-fulvic acid an acitve ingredient
AU1230800A (en) Controlled delivery of antidepressants
IL117097A0 (en) Substituted heterocycloalkenes their preparation and use
ES2170377T3 (es) Composicion que contiene quitosana.
HUT75939A (en) Intranasal composition containing active ingredient having antimigraine effect and chitosan
GR1003059B (el) Βαλσαμινοελαιολαδο προιον αναγεννησης μαλλιων
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees